Rankings
▼
Calendar
SNDX Q2 2016 Earnings — Syndax Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
SNDX
Syndax Pharmaceuticals, Inc.
$2B
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$305,000
Gross Profit
$305,000
100.0% margin
Operating Income
-$9M
-2830.8% margin
Net Income
-$8M
-2740.3% margin
EPS (Diluted)
$-0.47
QoQ Revenue Growth
+0.0%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$779,000
Balance Sheet
Total Assets
$128M
Total Liabilities
$22M
Stockholders' Equity
$106M
Cash & Equivalents
$14M
← FY 2016
All Quarters
Q3 2016 →
